Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

HSP70 stimulant

DRUG CLASS:

HSP70 stimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	binimetinib + STA-4783 Sensitive: D – Preclinical binimetinib + STA-4783 Sensitive : D	binimetinib + STA-4783 Sensitive: D – Preclinical binimetinib + STA-4783 Sensitive : D
GNAQ mutation	Uveal Melanoma	GNAQ mutation	Uveal Melanoma	binimetinib + STA-4783 Sensitive: D – Preclinical binimetinib + STA-4783 Sensitive : D	binimetinib + STA-4783 Sensitive: D – Preclinical binimetinib + STA-4783 Sensitive : D
GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	STA-4783 Sensitive: D – Preclinical STA-4783 Sensitive : D	STA-4783 Sensitive: D – Preclinical STA-4783 Sensitive : D
GNAQ mutation	Uveal Melanoma	GNAQ mutation	Uveal Melanoma	STA-4783 Sensitive: D – Preclinical STA-4783 Sensitive : D	STA-4783 Sensitive: D – Preclinical STA-4783 Sensitive : D
MPZL3 overexpression	Breast Cancer	MPZL3 overexpression	Breast Cancer	STA-4783 Resistant: D – Preclinical STA-4783 Resistant : D	STA-4783 Resistant: D – Preclinical STA-4783 Resistant : D